Microsoft word - cv fahimi 89-4

CURRICULUM VITAE
Personal information : Location Tehran , Iran. Tel.:0098 912 1940902 Offices: 1- Clinical Pharmacy Department, School of Pharmacy, Sahhid Beheshti University of Medical Sciences, Niayesh & Vali e Asr intercept, Opposite to Goharbin jewlery 2- Pharmaceutical Care Department, Masih Daneshvari Hospital, Beheshti University of Medical Telefax: 26109503 E-mail: [email protected] and Date of Birth: Sep. 22, 1971 Education/Degree Research Fellowship in Diabetes, Tulane Med. Center, New Orleans, LA, USA. Residency Training Program, Tehran University of Medical Sciences, Faculty of Pharmacy, Iran. Doctor of Pharmacy, Pharm. D. Tehran University of Medical Sciences, Faculty of Pharmacy, Iran. Licensure

¾ Pharmcy Licenses
• Iranian Board Certified Pharmacotherapy Specialist (BCPS) • Clinical Pharmacy Practitioner (Pharm. D.) • Registered Pharmacist (Iranian Medical Council ID :D-5185) ¾ Other Professional Licenses

• Training course on Pharmacovigilance,Uppsala- Sweden,
12-23 May 2003
• Drug & Therapeutic Committees (DTC) & Training of Trainers (TOT) Course,
ﺰﻳاﻮﺟ
1386 لﺎﺳ رد هﺎﮕﺸﻧاد ﻲﻤﻠﻋ
تﺄﻴﻫ ﺐﺨﺘﻨﻣ ﺮﮕﺸﻫوﮋﭘ
يرﻮﺸﻧاد
ﺢﻴﺴﻣ ﺰ
ﻛﺮﻣ رد 1388
لﺎﺳ رد ﻪﻧﻮﻤﻧ ﻲﻤﻠﻋ تﺄﻴﻫ
يﺮﻬﻄﻣ ﺪﻴﻬﺷ ﻲﺷزﻮﻣآ راﻮﻨﺸﺟ
ﻦﻴﻣﻮﺳ ردرﻮﺸﻛ رد ﺮﺗﺮﺑ ﻲﺷزﻮﻣآ ﺪﻨﻳآﺮﻓ هﺪﻧﺮﺑ

Professional & Clinical Experiences


Board of Clinical Pharmacy
Dec 2008- present
Position:
Secretary of Board of Clinical Pharmacy
Pharmaceutical Care Department, Masih Daneshvari Hospital: National
Research Institute of Tuberculosis and Lung Disease (NRITLD)
Aug 2004- present
Shahid Beheshti Medical University,
Tehran, Iran.
Position:
Head of Pharmaceutical Care Department
Services and activities:
Clinical pharmacy section is staffed by:
* Clinical pharmacy specialists (Pharmacotherapists)
* Pharmacologists
* Pharmacists
Consistent with the mission of the department of Clinical Pharmacy (Pharmacotherapy),
located in Pharmacy School, programs focus on activities that contribute directly to
professional and scientific works resulting in advancement of practice, safety, education
and optimizing drug therapy in the hospital.
The activities are listed below:
1. Anticoagulation management services (inpatient and out patient) 2. Drug safety (drug -
related morbidity, adverse drug reaction, dose individualization, interaction, special
patient population monitoring, medication errors, .)
3. Management and strategy (implementing management strategy in hospital pharmacy,
reengineering of services to meet new demands, addressing leadership questions .)
4. Drug information (drug information on a specific disease, development in information
delivery .)
5. Clinical Pharmacy (intervention, patient specific pharmacotherapy, outcome
assessment .)
6. Hospital pharmacy practice (formulary management, DTC IV admixture)
7. Monthly ADR bulletin (mainly devoted to interesting cases detected in the hospital)
8. Clinical pharmacokinetics (Calculation, TDMs, .)
9. Clinical pharmacy researches (mostly designed to result in optimal pharmaceutical
care)
10. Pharmacy student and clinical pharmacy resident education
11. Basic pharmacological researches aimed at investigating cellular mechanism of drug
handling and toxicity(e.g. polymorphism)
12. Pharmacoeconomy (DUR, Quality of life, Cost-effectiveness, CMA .)
13. Drug protocols and treatment guidelines : establishment, implementation and
evaluation.

Community Pharmacy Externship Course Coordinator & Instructor
Faculty of Pharmacy,
Shaheed Beheshti Medical University,
Tehran, Iran.
June 2000-2003
Drug Information Course Coordinator & Instructor
Faculty of Pharmacy,
Shaheed Beheshti Medical University,
Tehran, Iran.
Sep. 1999-2002

Pharmacy Consultant
Tehran Emergency Building, Poison Information Center
Feb. 1999- Feb. 2001
Vice Pharmacy Consultant
Dubai Iranian Hospital
Aug. 2000- Sep. 2000
Medical Rep.(Product Specialist)
Glaxo-Welcome Pharmaceutical Company (Tehran office: Jahan Behbood)
Feb. 1998- Apr. 1998 (Quited to start residency program)
Staff Pharmacist
Polyclinic Pharmacy
Imam Khomeini General Hospital
May 1997-May 1998
Pharmacy Manager
Pediatric Amirkabir Hospital
June 1995-May 1997

Publications:
1. Fahimi F, Moradi M, Safarnavadeh T, Namdar R. Review of the management of community acquired pneumonia in a teaching hospital: assessment of the role of established guidelines. Tanaffos. Oct. 2007;6(2): 35-40 2. Fahimi F, Baniasadi S, Malekmohammad M. Neurologic and Psychotic Reaction Induced by Lidocaine. Journal of Bronchology 2007;14(1):57-8 3. Baniasadi S, Fahimi F, Shalviri G. Developing an adverse drug reaction reporting system at a teaching hospital. Basic Clin Pharmacol Toxicol. 2008; 102(4):408-11 4. Fahimi F, Sistanizad M, Abrishami R, Baniasadi S. An observational study of errors related to the preparation and administration of medications given by infusion devices in a teaching hospital. Iranian J Pharm Res 2007;6(4): 295-9 5. Fahimi F, Ariapanah P, Faizi M, Shafaghi B, Namdar R, Tavakoli Ardakani M. Errors in preparation and administration of intravenous medications in the intensive care unit of a teaching hospital: an observational study. Aust Crit Care. 2008 May; 21(2):110-6 6. Baniasadi S, Fahimi F, Shalviri G. Developing an adverse drug reaction reporting system at a teaching hospital. Basic Clin Pharmacol Toxicol. 2008; 102(4):408-11 7. Fahimi F, Baniasadi S, Amini S. Adverse drug reactions in the post coronary care unit inpatients of a teaching hospital. Iranian J Pharm Res 2008;7(3): 223-8 8. Fahimi F, Abbasi Nazari M, Abrishami R, Sistanizad M, Mazidi T, Faghihi T, Soltani R, Baniasadi S. Transcription errors observed in a teaching hospital. Arch Iran Med 2009;12(2):173-5 9. Baniasadi S, Fahimi F, Namdar R. Development of an adverse drug reaction bulletin in a teaching hospital. Formulary 2009; 44:333-5. 10. Fahimi F, Baniasadi S, Najafizadeh K. Does switch to another dosage form of Neoral increase the risk of medication error? Ann Transplant 2009;14(4):58-60 11. Fahimi F, Salamzadeh J, Jamaati HR, Sohrabi S, Fakharian A, Mohammadtaheri Z. Do statins improve lung function in asthmatic patients? A randomized and double-blind trial. IJPS, 2009; 5(1): 13-20 12. Baghaei P, Tabarsi P, Chitsaz E, Saleh M, Marjani M, Shemirani S, Pooramiri MV, Kazempour M, Farnia P, Fahimi F, Mansouri D, Masjedi M. Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases. Am J Ther. 2010;17(1):17-22 13. Dezfouli AA, Najafizadeh K, Parsa T, Shadmehr MB, Dabir S, Mohammadi F, Tabarsi P, Lankarani MM, Assari S, Marjani M, Fahimi F, Shafaghi S, Faeghi J, Masjedi MR. Postlung transplant rehospitalization: a study of causes, health care burden, and outcomes. Exp Clin Transplant. 2009 Sep;7(3):192-6 14. Baniasadi S, Beizaee S, Kazemi B, Behzadnia N, Shafaghi B, Bandehpour M, Fahimi F. Novel VKORC1 Mutations Associated with Warfarin Sensitivity. Cardiovasc Ther. 2010. [Epub ahead of print] 15. Baniasadi S, Eftekhari P, Tabarsi P, Fahimi F, Raoufy MR, Masjedi MR, Velayati AA. Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity. Eur J Gastroenterol Hepatol. 2010. [Epub ahead of print] 16. Fahimi F. Implementation of a clinical pharmacy education program: Resident oriented documentation and intervention. Iranian J Pharm Res (In press) 17. Tavallaee , Fahimi F, Kiani S, Drug use patterns in an Intensive Care Unit of a hospital in Iran: an observational prospective study. International Journal of Pharmacy Practice. (In Press)

Submitted manuscripts

Fahimi F, Kobarfard F, Tabarsi P, Hemmati S, Baniasadi S, Salamzadeh J, Isoniazid blood levels in patients with pulmonary tuberculosis at a tuberculosis referral center. Chemotherapy. (Responded to review) Fahimi F, Amini S, Khodadad K, Naghibi F, Salamzadeh J, Baniasadi S. Evaluation of the effect of zingiber officinalis on nausea and vomiting in patients receiving cisplatin based regimens Alternative and Complementary Therapies. (Responded to review) Fahimi F, Namdar R, Mousavi S, Ziaee S, Sharif-Kashani B, Tavalayee M, Baniasadi S. The first pharmacist based warfarin monitoring service in Iran. International Journal of Medicine and Medical Sciences. (Responded to review) Fahimi F, Sahraee Z, Amini S. Evaluation of Stat Orders in a Teaching Hospital. Clinical Drug Investigation. (Responded to review) Haj Hossein Talasaz A, Fahimi F, Jahangard Rafsanjani Z, Ziaie S. Drug utilization evaluation of human albumin in a teaching hospital. AIM. (Under review) Fahimi F, Kobarfard F, Salamzadeh J, Fakharian A, Abdollahi P, Talasaz A, Baniasadi S, Masjedi MR. The comparison between two common types of spacers in respiratory indices alteration (FEV1) and the bioavailability of albuterol using urine specimen of asthmatic patients in Masih Daneshvari Hospital. Journal of Aerosol Medicine and Pulmonary Drug Delivery. (Under review)
Prepared manuscript for submission
Fahimi F, Soleymani F, Tavakoli M. Vancomycin utilization evaluation in a teaching hospital: A case- series study in Iran, Pharmacy Practice. Fahimi F, Ememi S, Rashid Farrokhi F. The rate of antibiotic dosage adjustment in renal dysfunction at a university hospital. Fahimi F, Adimi P, Naji SA, Naderi N, Morovvati S, Soleymani F, Masjedi MR. The evaluation of pharmacogenetic relationship of beta 2-adrenoceptors and response to salmeterol. Fahimi F, Sharif-Kashani B, Hamraghani A, Salamzadeh J, Baniasadi S. NT-proBNP levels in COPD patients with secondary pulmonary hypertension receiving sildenafil or amlodipine. Published Books:

1. Applied tables for physicians and pharmacists. 2. Questions and answers in asthma and COPD. 3. Questions and answers in tuberculosis, pneumonia, and swine flu. 4. What is warfarin? 5. Quick guide for preparation and administration of IV drugs in ICU. 6. Educational handbook on the medication of organ transplanted patients. 7. Drug and therapeutic committee. 8. Medication cessation before surgery. (In press) • Selected Abstracts:
INTL-61 Citation: “Estimating the Precentage of Generic and Parenteral Medications Dispensed as Well as Missing Information on 5100 Prescriptions Filled at Community Pharmacies in Tehran. Fanak Fahimi, Bidjan Djahanguiri, Soha Namazi, and Aziz Delfan Dec., 2001, INTL-81 Citation: “Dosage Evaluation of Propranolol in Iranian Patients with Cardiovascular Diseases.” (Iran), Soha Namazi, Mojtaba Mojtahedzadeh, Fanak Fahimi, and Katayuon Kaviani Dec., 2001, International ASHP Congress, New Orleans, LA ,USA. “The correlation between Leptin & Fasting”, Oct. 10-12,2001, The Congress of Health & Ramadan, Tehran, Iran. “Leptin & obesity”, Oct. 5-9, 2001, 6th International Congress of Endocrine Disorders, Tehran, Iran. “The influence of education in children with ADHD & affective D/O on compliance their impovements” Aug. 27-29, 2002, 8th Iranian Seminar of Pharmaceutical Sciences, Tehran, Iran.
“Which is a better alternative? Study of 404 prescriptions from pharmacoeconomic
point of view in Tehran”(lecture)
Aug. 27-29, 2002,
8th Iranian Seminar of Pharmaceutical Sciences,
Tehran, Iran.
1. “Metformin utilization review in Medical Center of Luisiana, June 2004”
And
2. “A pilot study of commonly used drugs and its impact on economy: A cost
minimization analysis.”
March, 2005
10th European Association of Hospital Pharmacists (EAHP)
Lisbon, Portugal
1. “Comparative efficacy of glycerin suppositories in the elderly with functional
constipation.”
And
2. “Transcription Errors Observed in a Teaching Hospital”
And
3. “An Observational study in accuracy of infusion pumps implications and related
admixture compatibility in an intensive care unit of a teaching hospital.”
Oct. 2006,
35th European Symposium on Clinical Pharmacy (ESCP)
Vienna, Austria.
1. Salamzadeh J, Fahimi F, Nematollahi M. “Evaluation of the utilization patterns of anti-
asthma medications at a university hospital. “ ELECTRONIC POSTER
DISCUSSION
And
2. Fahimi F, Salamzadeh J, Jamaati HR, Fakharian A, Sohrabi S, Mohammadtaheri Z.
“Does atorvastatin have effect on lung function and morbidity as add-on therapy
in asthmatic patients? ORAL PRESENTATION
ERS Sep. 2007 Congress.
Stockholm, Sweden.

Professional Affiliation:

Iranian Medical Council Organization
Central ADR monitoring center committee (Ministry of Health)
ADR news evaluation committee (Ministry of Health)
DTC & Formulary Committee (Masih Daneshvari Hospital)
Mortality Committee (Masih Daneshvari Hospital)
Drug & Poison Information Center (Shahid Beheshti University of Medical Sciences)

Position held:
Clinical Pharmacy Board Secretary
Head of the Pharmaceutical Care Department at Masih Daneshvari Hospital

References:

• Available upon request.
• http://www.sbmu.ac.ir/SiteDirectory/PharmacySchool/Pages/Facultymembers.aspx
• http://www.google.com/search?sourceid=navclient&ie=UTF- 8&rls=GGLR,GGLR:2006-46,GGLR:en&q=Fanak+Fahimi • http://www.clinicalpharmacy.ir/default-58.aspx

Source: http://en.sbmu.ac.ir/uploads/CV_Dr.Fahimi.pdf